CCSD code 0021G: Mdm2 gene amplification test billing guide

Key Takeaways

CCSD Code 0021G is a diagnostic pathology code within the CCSD schedule that identifies the Mdm2 gene amplification test, listed under Chapter 34 — Pathology (Biochemistry, Genetic Analysis).

All major UK private medical insurers, including Bupa, AXA Health, Aviva, and Vitality, require valid CCSD codes on every claim submitted for reimbursement.

Incomplete clinical documentation, missing requesting clinician details, or incorrect code sequencing are the most common reasons claims for this code are rejected.

Pabau’s claims management software helps UK private practices submit CCSD-coded invoices electronically via Healthcode, reducing rejection rates and administrative overhead.

CCSD Code 0021G is a diagnostic pathology code in the Clinical Coding and Schedule Development (CCSD) Group schedule. It identifies the Mdm2 gene amplification test and sits within Chapter 34 of the schedule, under Biochemistry — Genetic Analysis. UK private practices and laboratories bill it through the same CCSD framework used across independent healthcare.

The shift from NHS to UK private practice billing introduces a new set of coding conventions, and CCSD codes sit at the centre of that system. This guide covers what CCSD Code 0021G identifies, which insurers accept it, what documentation a genetic pathology claim needs, and how to avoid the submission errors that trigger denials.

CCSD Code 0021G: definition and clinical scope

CCSD Code 0021G is listed within the Clinical Coding and Schedule Development (CCSD) Group schedule, the coding standard for the UK independent healthcare sector. It falls under Chapter 34 — Pathology, in the Biochemistry section covering Genetic Analysis, and identifies the Mdm2 gene amplification test.

The CCSD schedule is maintained jointly by major UK private medical insurers and healthcare providers to ensure consistent identification of clinical tests and procedures for billing and reimbursement.

The full test description for CCSD Code 0021G is held within the login-gated CCSD schedule, under Chapter 34 — Pathology (Biochemistry, Genetic Analysis). Because the schedule is access-controlled, UK laboratories and billing teams should verify the exact narrative directly via the CCSD website or the CCSD Technical Guide (October 2025 edition).

CCSD Code 0021G carries the “G” suffix designation, which in CCSD convention signals a specific variant within a parent code group, placing it within the broader 002x family of the schedule. For coding accuracy, the narrative text in your practice management system or laboratory information system must match the verified CCSD schedule description exactly.

CCSD schedule structure: where this code sits

Understanding how CCSD Code 0021G fits within the broader schedule prevents miscoding and bundling errors. The CCSD schedule is divided into several components, and knowing which one applies to your submission is a prerequisite for correct billing.

The CCSD Technical Guide specifies that pathology and diagnostic test codes (Chapter 34) are not procedure codes and should not be loaded into your procedure code table alongside Chapter 5 procedural codes. Mixing the two categories is a common source of submission errors.

Because CCSD Code 0021G sits in Chapter 34, load it into your laboratory or pathology test code table. For contrast, CCSD Code Y3811 sits in an entirely different chapter of the schedule, which illustrates why chapter assignment can’t be assumed from the code format alone.

For a practical look at how the schedule is organised for insurer submissions, see the Bupa CCSD codes guide.

Which insurers accept CCSD Code 0021G

All major UK private medical insurers base their claims processing on CCSD codes, whether the code sits in the procedural schedule or the pathology schedule. The Bupa procedure codes fee schedule reference is built around this standard, meaning CCSD Code 0021G will be recognised across the principal insurer platforms when submitted with the correct chapter assignment.

However, each insurer maintains its own fee schedule and may apply specific rules on reimbursement rates, pre-authorisation, and bundling for laboratory tests.

• Bupa: Uses CCSD codes as the industry standard. Submit via Bupa’s code search portal to confirm the code is listed and to check the applicable fee band before submitting a claim.
• AXA Health: Operates through its specialist procedure code portal and applies CCSD coding conventions. Pre-authorisation is required for most pathology and procedural codes.
• Aviva: Bases its fee schedule on CCSD codes. The Aviva fee schedule is published and updated periodically; verify current rates before invoicing.
• Vitality Health: Uses CCSD-based fees and provides a fee finder tool for practitioners to look up reimbursement by code.
• Allianz Care UK: Publishes a recognition fee schedule based on CCSD coding, with notes on bilateral procedures and unbundling requirements.
• Healix: Applies CCSD-based fees with explicit unbundling guidelines; review their Healix fee schedule before billing to avoid bundling-related rejections.
• WPA, H3 Insurance, Cigna UK: All use CCSD procedure coding as the basis for their fee schedules. H3 Insurance explicitly states its schedule is derived from the CCSD Schedule of Procedures.

Reimbursement rates for CCSD Code 0021G will vary by insurer and may change with each annual schedule update. Never state a fixed fee to a patient before verifying the current rate with the relevant insurer. Running a sustainable private practice depends on keeping these rates current across every payer you work with.

Documentation requirements for CCSD Code 0021G billing

Claim rejections for CCSD codes rarely happen because the code does not exist. They happen because the supporting documentation does not match what the insurer expects to see. The CCSD Technical Guide sets out core documentation principles that apply across all codes in the schedule, including pathology codes such as CCSD Code 0021G.

Required clinical record elements

• Requesting clinician’s name and GMC or GDC registration number
• Date the specimen was collected and the clinical indication for testing
• Specimen type and sample reference or accession number
• Confirmation of the accredited laboratory that performed the Mdm2 gene amplification test
• Test narrative matching the CCSD code description exactly
• Patient name, date of birth, and insurer membership number
• Pre-authorisation reference number (where required by the insurer)
• Result report attached to the billing record, including reporting pathologist details

Specimen collection is sometimes billed separately from the laboratory analysis itself. In US billing systems, for comparison, a specimen collection line item such as HCPCS Code G2023 is billed apart from the test code. UK billing teams should confirm with each insurer whether the CCSD schedule bundles specimen collection into 0021G or expects it as a separate line.

GDPR and record retention

UK private healthcare providers are subject to UK GDPR obligations, which require that clinical records supporting billing submissions are retained securely and for appropriate periods. A GDPR documentation checklist for UK practices can help ensure your record-keeping processes meet both insurer and regulatory requirements simultaneously.

Keeping digital consent and intake forms standardised across your team reduces the risk of incomplete records arriving at billing. A standardised diagnostic test documentation template, similar to the one used for amniocentesis referrals, keeps specimen and requesting-clinician details consistent across every genetic test ordered.

The same principle applies outside genetics: even an at-home cholesterol test needs a standardised results template to keep record-keeping consistent.

When a claim for CCSD Code 0021G is challenged, the first documents an insurer will request are the specimen request form and the lab report. If either is missing information, the rejection follows.

Meeting clinical compliance requirements in private practice means treating documentation as a billing asset, not just a clinical obligation. Every field completed at the point of specimen collection is one fewer query to resolve later.

Streamline your CCSD billing with Pabau

Pabau helps UK private practices manage CCSD-coded invoices, digital clinical records, and Healthcode submissions in one system, reducing claim rejections and administrative time.

Book a demo

How to submit CCSD Code 0021G correctly

Electronic claim submission via Healthcode is the standard channel for UK private healthcare billing. Healthcode processes claims on behalf of the major PMI insurers and applies a series of validation checks before the claim reaches the insurer. Understanding what those checks look for reduces the number of submissions that are returned before they are even reviewed.

Step-by-step submission process

1. Confirm the code is active: Log in to the CCSD schedule and verify that CCSD Code 0021G is currently active and that the narrative description matches the test performed. Retired or amended codes submitted as-is will reject.
2. Load the code into your test code table: Add the verified CCSD code and narrative to your practice management system exactly as listed in the schedule. Do not abbreviate the description.
3. Check insurer-specific requirements: Review the relevant insurer’s fee schedule to confirm the code is reimbursable for the patient’s policy type and that pre-authorisation has been obtained if required.
4. Complete the clinical record: Ensure the patient record includes all required fields (see documentation requirements above) before generating the invoice.
5. Generate and transmit the invoice electronically: Submit through Healthcode or your practice management system’s integrated billing module. Include the insurer membership number, authorisation reference, and correct requesting clinician details on every invoice.
6. Track the claim status: Monitor for any validation failures or insurer queries within the Healthcode portal. Respond to queries promptly; delayed responses can result in the claim being closed without payment.

The claims management software built into Pabau is designed to support this workflow, keeping CCSD-coded invoices, clinical records, and submission tracking in one place. For practices running high volumes of PMI claims, that centralisation meaningfully reduces the time spent chasing individual submission statuses.

Coding principles that affect submission

The CCSD Technical Guide sets out several coding principles that directly affect whether a claim is accepted. Unbundling rules prevent practices from splitting a single test or procedure into component codes to inflate reimbursement.

Bilateral rules require specific bilateral codes where both sides are treated in the same session. Sequencing rules determine which code should appear first when multiple codes are billed on the same invoice.

When submitting CCSD Code 0021G alongside another pathology code, such as CCSD Code 0019G, verify that the combination is permitted under the current CCSD coding principles bulletin. The January 2025 bulletin is publicly available and sets out current guidance on code combinations and sequence requirements.

Common reasons claims for CCSD Code 0021G are rejected

Understanding the most frequent rejection triggers for CCSD codes helps billing teams build a pre-submission checklist that catches errors before they reach the insurer. The same patterns appear repeatedly across UK private healthcare claims. Private GP and specialist practices operating across multiple insurers find that a consistent internal checklist reduces denials more reliably than any other single intervention.

• Code not pre-authorised: The insurer required prior approval and none was obtained before the test was carried out. The patient’s authorisation letter must be checked before every referral, not after.
• Incorrect or missing requesting clinician’s GMC number: Claims submitted without a valid GMC registration number for the requesting clinician are routinely rejected. This applies whether the test is billed on its own or alongside other codes on the same invoice.
• Test narrative mismatch: The lab report description does not match the CCSD code narrative. Insurers cross-reference the two; any discrepancy creates a query.
• Code bundling violation: CCSD Code 0021G has been submitted alongside another code that is considered inclusive under the coding principles, meaning only one code should be billed for the session.
• Claim submitted outside the time limit: Most insurers require claims to be submitted within a defined period after the date of service. Late submissions are often rejected without appeal rights.
• Patient membership lapsed: The patient’s PMI policy was not active on the date of the test. A membership validation check before the appointment prevents this entirely.

Practices using structured digital client records catch the majority of these errors before submission, because the required fields are built into the workflow rather than filled in retrospectively. The features that save private practices time in billing are almost always the ones that enforce documentation completeness at the point of care.

Conclusion

CCSD Code 0021G follows the same billing logic as every other code in the CCSD schedule: verify the current chapter and code description, obtain pre-authorisation where required, document the specimen and test completely, and submit electronically via Healthcode with all required fields present. The claims that fail are almost always the ones where one of those steps was skipped.

Pabau’s claims management software brings CCSD-coded invoicing, digital clinical records, and Healthcode submission tracking into a single workflow for UK private practices. If your team is managing a growing volume of PMI claims and finding the administration unsustainable, book a demo to see how Pabau handles CCSD billing in practice.

Continue your research

Need a documentation-focused walkthrough for a related code? The CCSD Code 0025B guide covers documentation and billing requirements for another entry in the schedule.

Billing another laboratory test code? The CCSD Code 0019B guide explains how the Alpha subunit (ASU) test is classified and billed under CCSD.

Looking at another diagnostic test code? The CCSD Code 0014B guide covers the acromegaly tolerance test and what to verify before configuring it in your billing system.

Frequently asked questions